Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer
ACT
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this randomized controlled trial is to evaluate the effectiveness of an empirically supported psychosocial treatment, Acceptance and Commitment Therapy, in facilitating improved quality of life, benefit-finding, and cortisol rhythm in breast cancer patients in an outpatient clinical oncology setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 15, 2010
CompletedFirst Posted
Study publicly available on registry
July 19, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedOctober 4, 2021
September 1, 2021
1.7 years
July 15, 2010
September 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
salivary cortisol
3-month follow-up
Secondary Outcomes (3)
self-reported distress
3-month follow-up
self-reported quality of life
3-month follow-up
self-reported benefit-finding
3-month follow-up
Study Arms (2)
Acceptance and Commitment Therapy group
EXPERIMENTAL8-week ACT group
Wait-list control group
NO INTERVENTIONParticipants will be offered treatment following wait-list data collection
Interventions
Eligibility Criteria
You may qualify if:
- diagnosis of stage I-III breast cancer
- prescreen distress score above defined cutoff
- agreement not to seek other breast cancer support services until study completion
You may not qualify if:
- previous cancer
- prior psychiatric treatment for serious mental health disorder (e.g., hospitalization or formal diagnosis of psychosis, major depressive episode, borderline mental retardation, suicidality, or current substance dependence)
- current use of medications known to interfere with cortisol levels (e.g., dexamethasone)
- major concurrent medical disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Jose State University
San Jose, California, 95192, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 15, 2010
First Posted
July 19, 2010
Study Start
January 1, 2010
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
October 4, 2021
Record last verified: 2021-09